Combination of loteprednol and antihistamines
Patent 7022687 Issued on April 4, 2006. Estimated Expiration Date: 
September 26, 2020. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
September 26, 2020. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesSoft steroids having anti-inflammatory activity Soft steroids having anti-inflammatory activity Patent #: 4996335 InventorsAssigneeApplicationNo. 10089436 filed on 09/26/2000US Classes:514/179, Modified C-ring (except methyl in 13-position) (e.g., double bond containing, substituted, etc.)514/217.05, Plural ring hetero atoms in the additional hetero ring514/330C=X bonded directly to the piperidine ring (X is chalcogen)ExaminersPrimary: Cook, RebeccaAttorney, Agent or FirmForeign Patent References
International ClassesA61K 31/56A61K 31/55 A61K 31/47 AbstractThe present invention relates to a novel combination of a soft steroid, in particular loteprednol, and at least one antihistamine, such as, for example, azelastine and/or levocabastine, for simultaneous, sequential or separate administration in the local treatment of allergies and airway disorders, for example of allergic rhinitis (rhinoconjunctivitis).Other References
| |
